---
figid: PMC9130392__12672_2022_497_Fig1_HTML
pmcid: PMC9130392
image_filename: 12672_2022_497_Fig1_HTML.jpg
figure_link: /pmc/articles/PMC9130392/figure/Fig1/
number: Fig. 1
figure_title: ''
caption: mTOR signaling pathway in cancer (revised from Zoncu et al. Nature Reviews.
  2011 12:21–35). 4E-BP1 eukaryotic translation initiation factor 4E-binding protein
  1; Akt protein kinase B; HIF1α hypoxia-inducible factor 1α; eIF-4E eukaryotic translation
  initiation factor 4E; mTORC1 mammalian Target of Rapamycin complex 1; mTORC2 mammalian
  Target of Rapamycin complex 2; Rheb Ras Homologue enriched in brain; S6K1/2 p70
  ribosomal S6 kinase 1 and 2; SGK serum- and glucocorticoid-regulated kinase; SREBP1
  sterol regulatory element binding protein 1c; TSC1/2 tuberous sclerosis protein
  1 and 2
article_title: mTOR pathway gene expression in association with race and clinicopathological
  characteristics in Black and White breast cancer patients.
citation: Mmadili N. Ilozumba, et al. Discov Oncol. 2022 Dec;13:34.
year: '2022'

doi: 10.1007/s12672-022-00497-y
journal_title: Discover. Oncology
journal_nlm_ta: Discov Oncol
publisher_name: Springer US

keywords:
- mTOR
- Gene expression
- Breast cancer
- Race
- Clinicopathological characteristics

---
